Skip to main content

Table 1 Demographics

From: CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial

 Number of participants, N (%)
Placebo (N = 102)DNX 5 mg (N = 102)DNX 10 mg (N = 103)DNX 25 mg (N = 103)DNX 35 mg (N = 102)DNX 50 mg (N = 102)
Age (years)
 Mean (SD)66.2 (7.3)66.3 (6.8)65.7 (7.5)66.3 (7.3)65.1 (7.6)65.7 (7.0)
 Median67.066.566.067.065.066.0
Age group (years)
 18–6443 (42)38 (37)45 (44)40 (39)46 (45)47 (46)
 65–7446 (45)52 (51)47 (46)47 (46)45 (44)40 (39)
 75–8413 (13)12 (12)11 (11)16 (16)11 (11)15 (15)
Sex
 Female29 (28)36 (35)32 (31)38 (37)35 (34)32 (31)
 Male73 (72)66 (65)71 (69)65 (63)67 (66)70 (69)
Ethnicity
 Hispanic/Latino1 (< 1)01 (< 1)3 (3)1 (< 1)3 (3)
 Not Hispanic/Latino101 (> 99)102 (100)102 (> 99)100 (97)101 (> 99)99 (97)
Race
 Asian - East Asian Heritage10 (10)6 (6)18 (17)17 (17)10 (10)17 (17)
 Asian - South East Asian Heritage1 (< 1)00000
 Black or African American2 (2)2 (2)1 (< 1)001 (< 1)
 Native Hawaiian or other Pacific Islander1 (< 1)00000
 White - Arabic/North African Heritage1 (< 1)1 (< 1)0000
 White - White/Caucasian/European Heritage87 (85)93 (91)84 (82)86 (83)92 (90)84 (82)